We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.4%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$27.8B
AUM Growth
+$2.54B
(+10%)
Cap. Flow
+$477M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
17.19%
Holding
2,397
New
92
Increased
1,264
Reduced
960
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$37.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$35.5M |
| 3 |
Verizon
VZ
|
+$26.4M |
| 4 |
Truist Financial
TFC
|
+$26.1M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$53.1M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$25.3M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$16.9M |
| 4 |
CUK
Carnival PLC
CUK
|
+$15M |
| 5 |
WBK
Westpac Banking Corporation
WBK
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.1% |
| 2 | Financials | 16.78% |
| 3 | Healthcare | 13.34% |
| 4 | Consumer Discretionary | 9.48% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
National CineMedia
NCMI
$375M
| $307K | ﹤0.01% |
4,212
-226
| -5% | -$17K |
|
2052
StoneX
SNEX
$9.39B
| $307K | ﹤0.01% |
31,853
-962
| -3% | -$7.96K |
|
2053
El Pollo Loco
LOCO
$502M
| $305K | ﹤0.01% |
20,113
+289
| +1% | +$4.04K |
|
|
AIMT
2054
DELISTED
Aimmune Therapeutics
AIMT
| $305K | ﹤0.01% |
+9,124
| New | +$255K |
|
2055
Editas Medicine
EDIT
$413M
| $303K | ﹤0.01% |
+10,233
| New | +$256K |
|
2056
Xencor
XNCR
$1.59B
| $303K | ﹤0.01% |
+8,809
| New | +$322K |
|
2057
Golub Capital BDC
GBDC
$3.34B
| $301K | ﹤0.01% |
16,640
+6,186
| +59% | +$109K |
|
2058
Prothena Corp
PRTA
$440M
| $301K | ﹤0.01% |
19,007
+3,423
| +22% | +$36.7K |
|
|
INFN
2059
DELISTED
Infinera Corporation Common Stock
INFN
| $301K | ﹤0.01% |
37,849
-7,214
| -16% | -$44.3K |
|
|
MRC
2060
DELISTED
MRC Global
MRC
| $300K | ﹤0.01% |
21,974
-6,977
| -24% | -$90.9K |
|
2061
Nelnet
NNI
$4.88B
| $300K | ﹤0.01% |
5,159
-74
| -1% | -$4.53K |
|
|
RPT
2062
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $300K | ﹤0.01% |
19,952
+4,414
| +28% | +$63K |
|
2063
Scholastic
SCHL
$789M
| $299K | ﹤0.01% |
7,779
+739
| +10% | +$27.8K |
|
2064
Cactus
WHD
$4.3B
| $299K | ﹤0.01% |
+8,713
| New | +$264K |
|
|
NGHC
2065
DELISTED
National General Holdings Corp
NGHC
| $299K | ﹤0.01% |
13,518
+448
| +3% | +$9.79K |
|
2066
Gray Television
GTN
$417M
| $297K | ﹤0.01% |
13,852
+1,634
| +13% | +$30.3K |
|
2067
Ironwood Pharmaceuticals
IRWD
$614M
| $297K | ﹤0.01% |
22,323
-3,491
| -14% | -$38.5K |
|
2068
Center Bancorp
CNOB
$1.66B
| $296K | ﹤0.01% |
11,521
-2,320
| -17% | -$56.5K |
|
2069
TransAlta
TAC
$4.06B
| $295K | ﹤0.01% |
41,145
-451
| -1% | -$2.93K |
|
|
LDL
2070
DELISTED
Lydall, Inc.
LDL
| $294K | ﹤0.01% |
14,316
-6,310
| -31% | -$131K |
|
2071
Warrior Met Coal
HCC
$4.25B
| $293K | ﹤0.01% |
13,848
+2,962
| +27% | +$60.5K |
|
2072
Shopify
SHOP
$159B
| $293K | ﹤0.01% |
+7,370
| New | +$249K |
|
|
PGTI
2073
DELISTED
PGT, Inc.
PGTI
| $293K | ﹤0.01% |
19,671
-4,466
| -19% | -$71K |
|
|
MMP
2074
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $293K | ﹤0.01% |
4,666
-1
| -0% | -$62 |
|
2075
Cavco Industries
CVCO
$4.33B
| $292K | ﹤0.01% |
1,494
+87
| +6% | +$17.1K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q4 2019 Portfolio in Review
As of Q4 2019, Aperio Group held 2,397 positions worth $27.8B, up 10% from $25.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Aperio Group's Q4 2019 filing shows 92 new, 1,264 increased, 960 reduced and 73 closed positions. Its largest new stake was Cerence: 67,887 shares worth $1.54M. The largest sale was Celgene Corp, an estimated $53.1M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2019 buy was Cerence: 67,887 shares worth $1.54M.
- Aperio Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $37.3M increase.
- Aperio Group's biggest Q4 2019 reduction was China Mobile Limited, cutting an estimated $16.9M.
- Aperio Group fully exited Celgene Corp in Q4 2019, selling an estimated $53.1M.
- Aperio Group's ten largest holdings make up 17% of its $27.8B portfolio in Q4 2019.
- Aperio Group opened 92 new positions and closed 73 in Q4 2019.
- Aperio Group's portfolio value rose 10% quarter-over-quarter to $27.8B.
Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.